HUE065201T2 - Heterociklusos szubsztituált piridinszármazék gombaellenes szerek - Google Patents

Heterociklusos szubsztituált piridinszármazék gombaellenes szerek

Info

Publication number
HUE065201T2
HUE065201T2 HUE18885399A HUE18885399A HUE065201T2 HU E065201 T2 HUE065201 T2 HU E065201T2 HU E18885399 A HUE18885399 A HU E18885399A HU E18885399 A HUE18885399 A HU E18885399A HU E065201 T2 HUE065201 T2 HU E065201T2
Authority
HU
Hungary
Prior art keywords
antifungal agents
pyridine derivative
substituted pyridine
heterocycle substituted
derivative antifungal
Prior art date
Application number
HUE18885399A
Other languages
English (en)
Inventor
Michael Trzoss
Jonathan Covel
Karen Joy Shaw
Peter Webb
Original Assignee
Amplyx Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amplyx Pharmaceuticals Inc filed Critical Amplyx Pharmaceuticals Inc
Publication of HUE065201T2 publication Critical patent/HUE065201T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HUE18885399A 2017-12-07 2018-12-07 Heterociklusos szubsztituált piridinszármazék gombaellenes szerek HUE065201T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762595894P 2017-12-07 2017-12-07
US201862649225P 2018-03-28 2018-03-28

Publications (1)

Publication Number Publication Date
HUE065201T2 true HUE065201T2 (hu) 2024-05-28

Family

ID=66751743

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18885399A HUE065201T2 (hu) 2017-12-07 2018-12-07 Heterociklusos szubsztituált piridinszármazék gombaellenes szerek

Country Status (19)

Country Link
US (2) US11512079B2 (hu)
EP (1) EP3720438B1 (hu)
JP (2) JP7292299B2 (hu)
KR (1) KR20200096941A (hu)
CN (1) CN111698989B (hu)
AU (1) AU2018379077B2 (hu)
BR (1) BR112020011162A2 (hu)
CA (1) CA3084298A1 (hu)
DK (1) DK3720438T3 (hu)
ES (1) ES2962986T3 (hu)
FI (1) FI3720438T3 (hu)
HU (1) HUE065201T2 (hu)
IL (1) IL275121A (hu)
MA (1) MA51052A (hu)
MX (1) MX2020005927A (hu)
PL (1) PL3720438T3 (hu)
PT (1) PT3720438T (hu)
WO (1) WO2019113542A1 (hu)
ZA (1) ZA202003281B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019113542A1 (en) 2017-12-07 2019-06-13 Amplyx Pharmaceuticals, Inc. Heterocycle substituted pyridine derivative antifungal agents
CA3104653A1 (en) 2018-06-25 2020-01-02 Amplyx Pharmaceuticals, Inc. Pyridine derivatives substituted by heterocyclic ring and amino group
WO2020247804A1 (en) * 2019-06-07 2020-12-10 Amplyx Pharmaceuticals, Inc. Heterocycle substituted pyridine derivative antifungal agents
WO2021178406A1 (en) * 2020-03-04 2021-09-10 Amplyx Pharmaceuticals, Inc. Use of compounds in the treatment of fungal infections

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
JP2594486B2 (ja) 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
HUP0001741A3 (en) * 1996-08-02 2000-11-28 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
AU2002253432B2 (en) 2001-04-05 2005-03-24 Torrent Pharmaceuticals Ltd. Heterocyclic compounds for aging-related and diabetic vascular complications
JO2785B1 (en) * 2003-05-27 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinazoline derivatives
AU2006309762B2 (en) * 2005-10-31 2010-02-25 Eisai R&D Management Co., Ltd. Heterocyclic substituted pyridine derivatives and antifungal agent containing same
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
JP5525812B2 (ja) * 2006-04-19 2014-06-18 メルク セローノ ソシエテ アノニム Mekインヒビターとしての新規ヘテロアリール置換アリールアミノピリジン誘導体
DE102006020327A1 (de) * 2006-04-27 2007-12-27 Bayer Healthcare Ag Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung
KR20100015897A (ko) 2007-04-27 2010-02-12 에자이 알앤드디 매니지먼트 가부시키가이샤 헤테로환 치환 피리딘 유도체의 염 또는 그의 결정
TW200841879A (en) 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
US20100284993A1 (en) * 2007-10-24 2010-11-11 Mutz Mitchell W Enhancing the Efficacy of Anti-Infective Therapeutics
RU2474581C2 (ru) 2007-12-26 2013-02-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Способ получения замещенных гетероциклом производных пиридина
US8513287B2 (en) 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
WO2010032874A1 (ja) * 2008-09-19 2010-03-25 住友化学株式会社 農業用組成物
US8188119B2 (en) 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
JP2012176900A (ja) 2009-06-24 2012-09-13 Eisai R & D Management Co Ltd ((ホスホノオキシ)メチル)ピリジニウム環を有するピリジン誘導体およびそれらを含有する抗真菌剤
WO2011051198A2 (de) * 2009-10-30 2011-05-05 Bayer Cropscience Ag Pyridin-derivate als pflanzenschutzmittel
WO2019113542A1 (en) 2017-12-07 2019-06-13 Amplyx Pharmaceuticals, Inc. Heterocycle substituted pyridine derivative antifungal agents
CA3104653A1 (en) 2018-06-25 2020-01-02 Amplyx Pharmaceuticals, Inc. Pyridine derivatives substituted by heterocyclic ring and amino group
WO2020247804A1 (en) 2019-06-07 2020-12-10 Amplyx Pharmaceuticals, Inc. Heterocycle substituted pyridine derivative antifungal agents

Also Published As

Publication number Publication date
ES2962986T3 (es) 2024-03-22
CA3084298A1 (en) 2019-06-13
IL275121A (en) 2020-07-30
PT3720438T (pt) 2023-12-07
EP3720438A1 (en) 2020-10-14
EP3720438A4 (en) 2021-06-16
EP3720438B1 (en) 2023-08-30
MA51052A (fr) 2021-04-21
CN111698989A (zh) 2020-09-22
WO2019113542A1 (en) 2019-06-13
BR112020011162A2 (pt) 2020-11-17
US11512079B2 (en) 2022-11-29
US20230065881A1 (en) 2023-03-02
JP7292299B2 (ja) 2023-06-16
KR20200096941A (ko) 2020-08-14
FI3720438T3 (fi) 2023-09-01
PL3720438T3 (pl) 2024-03-18
US20210163461A1 (en) 2021-06-03
AU2018379077A1 (en) 2020-06-25
MX2020005927A (es) 2020-10-07
ZA202003281B (en) 2023-10-25
AU2018379077B2 (en) 2023-04-27
JP2023113800A (ja) 2023-08-16
CN111698989B (zh) 2023-08-01
DK3720438T3 (da) 2023-10-02
JP2021505672A (ja) 2021-02-18

Similar Documents

Publication Publication Date Title
IL280573A (en) 2-(het)aryl-converted compressed heterocycles as pest control agents
ZA201807249B (en) Heterocyclic compound
ZA201803475B (en) Condensed bicyclic heterocycle derivatives as pest control agents
ZA201902232B (en) Pyridine compound
IL267850A (en) Heterocyclic derivatives as pest control agents
IL260908B (en) Substituted 2-(het)aryl-imidazolyl-carboxyamides as pest control agents
IL275121A (en) Heterocycle-modified pyridine derivatives antifungal agents
ZA201901596B (en) Condensed bicyclic heterocycle derivatives as pest control agents
IL267844A (en) Heterocyclic derivatives as pest control agents
IL260148A (en) Heterocyclene derivatives as pest control agents
IL260829B (en) Substituted imidazolyl-carboxamides as pest control agents
ZA201901024B (en) Condensed bicyclic heterocycle derivatives as pest control agents
IL272482A (en) A pyridine compound is transformed with an azole
PT3643718T (pt) Composto heterocíclico e seu uso como modulador alostérico positivo do recetor muscarínico colinérgico m1
IL260640B (en) Substituted 2-oxyimidazolyl-carboxamides as pest control agents
HK1256022A1 (zh) 唑類取代的吡啶化合物
EP3660003C0 (en) HETEROCYCLIC COMPOUND
ZA201701093B (en) Aryl-triazolyl pyridines as pest control agents
EP3693360C0 (en) HETEROCYCLIC COMPOUNDS
EP3693368C0 (en) HETEROCYCLIC COMPOUND
IL265578A (en) 5-substituted imidazolylmethyldioxolane derivatives as fungicides
ZA201807933B (en) Substituted 2-alkylimidazolyl-carboxamides as pest control agents
IL265638A (en) 5-substituted imidazolylmethyloxirane derivatives as fungicides
ZA201907793B (en) Heterocyclic compound
ZA201907792B (en) Heterocyclic compound